Page 21 - Read Online
P. 21

Castán et al.                                                                                                                                           Radiology of hepatocarcinoma in non-cirrhotic patients

            A                                B                                C
















            D                                E                                F
















           Figure 12: Computed tomography: axial planes obtained in arterial phase (A) and portal phase (B). Focal lesion in left hepatic lobe
           (yellow arrow) shows enhancement in the arterial phase (A) and is isodense in the portal phase (B) with central scar (red arrow). Magnetic
           resonance imaging: liver acquisition with volume acceleration dynamic sequences in axial planes: noncontrast phase (C), arterial phase
           (D), hepatocyte phase (E) and portal phase (F). Focal lesion is hypointense in noncontrast phase (C) with enhancement in arterial (D)
           and hepatocyte phases (E), with central scar. Lesion is isointense in delayed phase (F). Lesion shows typical radiological findings of focal
           nodular hyperplasia

            Table 2: Magnetic resonance imaging differentiation between the three subtypes of hepatocellular adenoma
            Type                       T1             T1FF           T2                     T1 + C
            Inflammatory adenoma  Moderately hyperintense or  No signal drop Hyperintense, greater  Enhancement in arterial phase and persists
                              isointense                      peripheral intensity  in portal phase and late phase
            Mutated HNF1A     Hyperintense or isointense Hypointense  Isointense  Enhancement in arterial phase that does
            adenoma                                                            not persist in portal phase and late phase
            Mutated beta-catenin   Non specific pattern  Non specific   Non specific pattern  Similar to hepatocellular carcinoma:
            adenoma                                pattern                     enhancement in arterial phase and
                                                                               washing in portal phase and late phase

           HA is a rare benign tumor. It is currently classified   significant enhancement in the arterial phase. In portal
           into  4  subgroups  depending  on  their  genotype:   and late phases they differ by subtype: inflammatory
           inflammatory adenoma, mutated HNF1A adenoma,       adenoma  shows  a  persistent  enhancement,
           mutated beta-catenin hepatocellular adenoma and    mutated HNF1A adenoma is isodense regarding the
           unrated. They show different clinical behavior so their   parenchyma, mutated beta-catenin adenoma appears
           management is different. [53]                      hypervascular in the arterial phase and washes the
                                                              contrast like HCC [Figure 13].
           HA are hypervascular and heterogeneous lesions
           caused by foci of bleeding and may contain fat. Using   MRI is the technique of choice for the differentiation
           Doppler color, intra-lesional flow can be identified,   of the three subtypes, with the features shown in
           unlike  FNH  or  HCC,  and  it  does  not  produce  a   Table 2. Inflammatory adenoma is the most common
           pulsatile continuous curve. In CT they are well-defined   subtype. Histologically it is composed of inflammatory
           lesions, hypodense to isodense or slightly hyperdense   infiltrate and dilation of sinusoids. It is the subtype
           with respect to the parenchyma. They may have a    with the higher risk of bleeding. Mutated beta-catenin
           heterogeneous density and/or areas of hemorrhage.   adenoma is the least common subtype but that which
           In contrast CT they are hypervascular and show     presents the greater risk of malignant transformation

                           Hepatoma Research ¦ Volume 3 ¦ January 12, 2017                                 13
   16   17   18   19   20   21   22   23   24   25   26